192 related articles for article (PubMed ID: 6374406)
21. The zoonotic potential of reservoirs of leishmaniasis in the Old World.
Bray RS
Ecol Dis; 1982; 1(4):257-67. PubMed ID: 6765308
[TBL] [Abstract][Full Text] [Related]
22. [Experimental proof of the heterogeneous composition of natural Leishmania major populations for the virulence trait].
Kellina OI; Passova OM; Alekseev AN
Med Parazitol (Mosk); 1981; 50(6):4-11. PubMed ID: 7322024
[No Abstract] [Full Text] [Related]
23. Cost effectiveness in the discrimination of leishmania species causing anthroponotic leishmaniases in Asia using selective enzymes.
Shamsuzzaman SM; Hashiguchi Y
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):682-5. PubMed ID: 10928360
[TBL] [Abstract][Full Text] [Related]
24. [Intensified virulence of the causative agent in the process of the formation of a focus of cutaneous leishmaniasis].
Ni GV
Parazitologiia; 1982; 16(6):452-6. PubMed ID: 6218466
[TBL] [Abstract][Full Text] [Related]
25. Virulence and disease in leishmaniasis: what is relevant for the patient?
Rivas L; Moreno J; Cañavate C; Alvar J
Trends Parasitol; 2004 Jul; 20(7):297-301. PubMed ID: 15193556
[No Abstract] [Full Text] [Related]
26. Visceral leishmaniasis: host-parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host.
Saporito L; Giammanco GM; De Grazia S; Colomba C
Int J Infect Dis; 2013 Aug; 17(8):e572-6. PubMed ID: 23380419
[TBL] [Abstract][Full Text] [Related]
27. Discovery and study of Leishmania turanica for the first time in China.
Guan LR; Yang YQ; Qu JQ; Shen WX
Bull World Health Organ; 1995; 73(5):667-72. PubMed ID: 8846493
[TBL] [Abstract][Full Text] [Related]
28. Intra-specific variability of virulence in Leishmania infantum zymodeme MON-1 strains.
Baptista-Fernandes T; Marques C; Roos Rodrigues O; Santos-Gomes GM
Comp Immunol Microbiol Infect Dis; 2007 Jan; 30(1):41-53. PubMed ID: 17109961
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of serologic tests for the diagnosis of asymptomatic visceral leishmaniasis in an endemic area.
Romero HD; Silva Lde A; Silva-Vergara ML; Rodrigues V; Costa RT; Guimarães SF; Alecrim W; Moraes-Souza H; Prata A
Am J Trop Med Hyg; 2009 Jul; 81(1):27-33. PubMed ID: 19556562
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity and specificity of a recombinant Leishmania chagasi antigen in the serodiagnosis of visceral leishmaniasis.
Badaro R; Eulalio MC; Benson D; Freire M; Miranda JC; Pedral-Sampaio D; Burns JM; David JR; Johnson WD; Reed SG
Arch Inst Pasteur Tunis; 1993; 70(3-4):331-2. PubMed ID: 7802487
[No Abstract] [Full Text] [Related]
31. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
Ouaissi A; Ouaissi M
Arch Immunol Ther Exp (Warsz); 2005; 53(2):102-14. PubMed ID: 15928579
[TBL] [Abstract][Full Text] [Related]
32. Phlebotomine sand flies and Leishmania parasites: friends or foes?
Kamhawi S
Trends Parasitol; 2006 Sep; 22(9):439-45. PubMed ID: 16843727
[TBL] [Abstract][Full Text] [Related]
33. Genetics. Leishmania exploit sex.
Miles MA; Yeo M; Mauricio IL
Science; 2009 Apr; 324(5924):187-9. PubMed ID: 19359570
[No Abstract] [Full Text] [Related]
34. Molecular diagnosis of leishmaniasis.
Tavares CA; Fernandes AP; Melo MN
Expert Rev Mol Diagn; 2003 Sep; 3(5):657-67. PubMed ID: 14510185
[TBL] [Abstract][Full Text] [Related]
35. The molecular basis of Leishmania pathogenesis.
McConville MJ; Handman E
Int J Parasitol; 2007 Aug; 37(10):1047-51. PubMed ID: 17629957
[No Abstract] [Full Text] [Related]
36. [Leishmania tropica major cultures isolated from the red-tailed Libyan jird (Meriones libycus Lichtenstein, 1823) in the Turkmen SSR].
Lukmanova NE; Ponirovskiĭ EN
Med Parazitol (Mosk); 1980; 49(6):49-53. PubMed ID: 6451790
[No Abstract] [Full Text] [Related]
37. [Serodiagnosis of human visceral leishmaniasis and its evaluation of on the experimental practice].
Bugiardini G; Fabio U; Boni P; Pallotti G; Quaglio Fabio P
Nuovi Ann Ig Microbiol; 1973; 24(6):395-418. PubMed ID: 4603824
[No Abstract] [Full Text] [Related]
38. Animal models for the analysis of immune responses to leishmaniasis.
Sacks DL; Melby PC
Curr Protoc Immunol; 2015 Feb; 108():19.2.1-19.2.24. PubMed ID: 25640990
[TBL] [Abstract][Full Text] [Related]
39. Leishmania proteins derived from recombinant DNA: current status and next steps.
Kubar J; Fragaki K
Trends Parasitol; 2006 Mar; 22(3):111-6. PubMed ID: 16446114
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of leishmaniasis.
Elmahallawy EK; Sampedro Martinez A; Rodriguez-Granger J; Hoyos-Mallecot Y; Agil A; Navarro Mari JM; Gutierrez Fernandez J
J Infect Dev Ctries; 2014 Aug; 8(8):961-72. PubMed ID: 25116660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]